Patent · US Active

Human monoclonal antibodies to O8E

US9296822B2 · kind B2 · utility

5Cited by
32References
26Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 7, 2013
Grant dateMar 29, 2016
Priority date
Expiry dateApr 17, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N15/62
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure provides isolated monoclonal antibodies, particularly human monoclonal antibodies that specifically bind to O8E with high affinity. Nucleic acid molecules encoding the antibodies of this disclosure, expression vectors, host cells and methods for expressing the antibodies of this disclosure are also provided. Immunoconjugates, bispecific molecules and pharmaceutical compositions comprising the antibodies of this disclosure are also provided. This disclosure also provides methods for treating cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.